|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| G01N 33/574 |
| (11) | Number of the document | 3134119 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15729222.8 |
| Date of filing the European patent application | 2015-04-16 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/052796 |
| Date | 2015-04-16 |
| (87) | Number | WO 2015/162532 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 201461983951 P | 2014-04-24 | US |
| (72) |
MARTINI, Jean-Francois Andre, US
TARAZI, Jamal Christo, US
WILLIAMS, James Andrew, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CANCER TREATMENT |
| CANCER TREATMENT |